Priority Date: 03.02.12 (US 201261594532P)

COMBINATION THERAPY COMPRISING A GROWTH HORMONE VARIANT AND AN OLIGONUCLEOTIDE TARGETED TO THE GROWTH HORMONE RECEPTOR

  • Application ID: EP13743020
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Carpmaels & Ransford LLP is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 03.02.2012 - Priority Date (US 201261594532P)
  • 08.08.2013 - Publication A1 (WO2013113074)
  • 10.12.2014 - Publication A1 (EP2809400)

IPC Classification